Levels of uric acid in erectile dysfunction of different aetiology

References

• Kaya E, Sikka SC, Kadowitz PJ, et al. Aging and sexual health: getting to the problem. Aging Male. 2017;20:65–80.
   PubMed Web of Science ®Google Scholar
• Samipoor F, Pakseresht S, Rezasoltani P, et al. Awareness and experience of andropause symptoms in men referring to health centers: a cross-sectional study in Iran. Aging Male. 2017;20:153–160.
   PubMed Web of Science ®Google Scholar
• Goh WH, Hart WG. Association of general and abdominal obesity with age, endocrine and metabolic factors in Asian men. Aging Male. 2016;19:27–33.
   PubMed Web of Science ®Google Scholar
• Lue TF. Erectile dysfunction. N Engl J Med. 2000;342:1802–1813.
   PubMed Web of Science ®Google Scholar
• Paroni R, Barassi A, Ciociola F, et al. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and l-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction. Int J Androl. 2012;35:660–667.
   PubMedGoogle Scholar
• Yassin A, Saad F, Hoesl CS, et al. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS – implications for clinical practice. Andrologia. 2006;38:1–12.
   PubMed Web of Science ®Google Scholar
• Amano T, Earle C, Imao T, et al. Administration of daily 5 mg tadalafil improves endothelial function in patients with benign prostatic hyperplasia. Aging Male. 2017;22:1–6.
   Web of Science ®Google Scholar
• Kendirci M, Trost L, Sikka SC, et al. The effect of vascular risk factors on penile vascular status in men with erectile dysfunction. J Urol. 2007;178:2516–2520.
   PubMed Web of Science ®Google Scholar
• Barassi A, Colpi GM, Piediferro G, et al. Oxidative stress and antioxidant status in patients with erectile dysfunction. J Sex Med. 2009;6:2820–2825.
   PubMed Web of Science ®Google Scholar
• Dozio E, Barassi A, Dogliotti G, et al. Adipokines, hormonal parameters, and cardiovascular risk factors: similarities and differences between patients with erectile dysfunction of arteriogenic and nonarteriogenic origin. Sex Med. 2012;9:2370–2377.
   PubMed Web of Science ®Google Scholar
• Yassin A, Doros G. Testosterone therapy in hypogonadal men results in sustained and clinically meaningful weight loss. Clin Obes. 2013;3:73–83.
   PubMedGoogle Scholar
• Yassin D-J, Doros G, Hammerer PG, et al. Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life. J Sex Med. 2014;11:1567–1576.
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship J, Talib RA, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male. 2016;19:64–69.
   PubMed Web of Science ®Google Scholar
• Saad F, Yassin A, Almehmadi Y, et al. Effects of long-term testosterone replacement therapy, with a temporary intermission, on glycemic control of nine hypogonadal men with type 1 diabetes mellitus – a series of case reports. Aging Male. 2015;18:164–168.
   PubMed Web of Science ®Google Scholar
• Salman M, Yassin D-J, Shoukfeh H, et al. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy. Aging Male. 2017;20:45–48.
   PubMed Web of Science ®Google Scholar
• Park JH, Jin YM, Hwang S, et al. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development. Nitric Oxide. 2013;32:36–42.
   PubMed Web of Science ®Google Scholar
• Kirilmaz U, Guzel O, Aslan Y, et al. The effect of lifestyle modification and glycemic control on the efficacy of sildenafil citrate in patients with erectile dysfunction due to type-2 diabetes mellitus. Aging Male. 2015;18:244–248.
   PubMed Web of Science ®Google Scholar
• Matheus AS1, Tibiriçá E, da Silva PB, et al. Uric acid levels are associated with microvascular endothelial dysfunction in patients with type 1 diabetes. Diabet Med. 2011;28:1188–1193.
   PubMed Web of Science ®Google Scholar
• Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11:319–326.
   PubMed Web of Science ®Google Scholar
• Aversa A, Bruzziches R, Spera G. Diagnosing erectile dysfunction: the penile dynamic colour duplex ultrasound revisited. Int J Androl. 2005;28:61–63.
   PubMedGoogle Scholar
• Pezzilli R, Corsi MM, Barassi A, et al. Serum adhesion molecules in acute pancreatitis: time course and early assessment of disease severity. Pancreas. 2008;37:36–41.
   PubMed Web of Science ®Google Scholar
• Dozio E, Barassi A, Dogliotti G, et al. Comment on: adipokines, hormonal parameters, and cardiovascular risk factors: similarities and differences between patients with erectile dysfunction of arteriogenic and nonarteriogenic origin. J Sex Med. 2013;10:613.
   PubMed Web of Science ®Google Scholar
• Crane JK, Mongiardo KM. Pro-inflammatory effects of uric acid in the gastrointestinal tract. Immunol Invest. 2014;43:255–266.
   PubMed Web of Science ®Google Scholar
• Salvatore S, Finazzi S, Barassi A, et al. Low fecal elastase: potentially related to transient small bowel damage resulting from enteric pathogens. J Pediatr Gastroenterol Nutr. 2003;36:392–396.
   PubMed Web of Science ®Google Scholar
• Mert KU, Dural M, Mert GO, et al. Effects of heart rate reduction with ivabradine on the international ındex of erectile function (IIEF-5) in patients with heart failure. Aging Male. 2017;26:1–6.
   Google Scholar
• Paunksnis AL, Evangelista MR, La Scala Teixeira CV, et al. Metabolic and hormonal responses to different resistance training systems in elderly men. Aging Male. 2017;22:1–5.
   Google Scholar
• Barassi A, Pezzilli R, Colpi GM, et al. Vitamin D and erectile dysfunction. J Sex Med. 2014;11:2792–2800.
   PubMed Web of Science ®Google Scholar
• Long H, Jiang J, Xia J, et al. Hyperuricemia is an independent risk factor for erectile dysfunction. J Sex Med. 2016;13:1056–1062.
   PubMedGoogle Scholar
• Schlesinger N, Radvanski DC, Cheng JQ, et al. Erectile dysfunction is common among patients with gout. J Rheumatol. 2015;42:1893–1897.
   PubMed Web of Science ®Google Scholar
• Salem S, Mehrsai A, Heydari R, et al. Serum uric acid as a risk predictor for erectile dysfunction. J Sex Med. 2014;11:1118–1124.
   PubMed Web of Science ®Google Scholar
• Yassin AA, Almehmadi Y, Saad F, et al. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men. Clin Endocrinol. 2016;84:107–114.
   PubMed Web of Science ®Google Scholar
• Solomon H, Man JW, Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart. 2003; 89:251–253.
   PubMed Web of Science ®Google Scholar
• Almehmadi Y, Yassin D-J, Yassin AA. Erectile dysfunction is a prognostic indicator of comorbidities in men with late onset hypogonadism. Aging Male. 2015;18:186–194.
   PubMed Web of Science ®Google Scholar
• Barassi A, Pezzilli R, Morselli-Labate AM, et al. Evaluation of high sensitive troponin in erectile dysfunction. Dis Markers. 2015;2015:548951.
   PubMed Web of Science ®Google Scholar
• Solak Y, Akilli H, Kayrak M, et al. Uric acid level and erectile dysfunction in patients with coronary artery disease. J Sex Med. 2014;11:165–172.
   PubMedGoogle Scholar
• Puddu P, Puddu GM, Cravero E, et al. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012;59:235–242.
   PubMed Web of Science ®Google Scholar
• Sánchez-Lozada LG, Soto V, Tapia E, et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol. 2008;295:F1134–F1141.
   PubMed Web of Science ®Google Scholar
• Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295:C1183–C1190.
   PubMed Web of Science ®Google Scholar
• Barassi A, Corsi Romanelli MM, Pezzilli R, et al. Levels of l-arginine and l-citrulline in patients with erectile dysfunction of different aetiology. Andrology. 2017;5:256–261.
   PubMed Web of Science ®Google Scholar
• Basat S, Sivritepe R, Ortaboz D, et al. The relationship between vitamin D level and erectile dysfunction in patients with type 2 diabetes mellitus. Aging Male. 2017;23:1–5.
   Web of Science ®Google Scholar
• Corry DB, Eslami P, Yamamoto K, et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system. J Hypertens. 2008;26:269–275.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Sánchez-Lozada LG, Franco M, et al. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Nephrol Dial Transplant. 2011;26:430–437.
   PubMed Web of Science ®Google Scholar
• Dean RC, Lue TF. Physiology of penile erection and pathophysiology of erectile dysfunction. Urol Clin N Am. 2005;32:379–395.
   PubMed Web of Science ®Google Scholar
• Erdogan D, Gullu H, Caliskan M, et al. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults. Int J Clin Pract. 2005;59:1276–1282.
   PubMed Web of Science ®Google Scholar
• Butler R, Morris AD, Belch JJ, et al. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35:746–751.
   PubMed Web of Science ®Google Scholar
• Farquharson CA, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221–226.
   PubMed Web of Science ®Google Scholar
• Kanbay M, Huddam B, Azak A, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6:1887–1894.
   PubMed Web of Science ®Google Scholar
• Guthikonda S, Sinkey C, Barenz T, et al. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation. 2003;107:416–421.
   PubMed Web of Science ®Google Scholar
• Grayson PC, Kim SY, LaValley M, et al. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63:102–110.
   PubMed Web of Science ®Google Scholar